Pharmaceutical Excipients Market Forecast Highlights Expansion From $11529.86 Billion To $14866.99 Billion Through 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Pharmaceutical Excipients Market Growth From $11529.86 Billion In 2026 To $14866.99 Billion By 2030 At A CAGR Of 6.6%
In recent years, the market for pharmaceutical excipients has experienced robust expansion. Projections indicate an increase from $10,822.05 billion in 2025 to $11,529.87 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.5%. This historic growth has been driven by a rising need for oral dosage forms, a surge in pharmaceutical production within the Asia-Pacific region, greater utilization of synthetic excipients, rigorous regulatory approvals, and heightened research and development activities in drug formulation.
Projections indicate robust expansion for the pharmaceutical excipients market over the coming years, with its value anticipated to reach $14,867 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.6%. This forecasted growth is driven by factors such as the rise of personalized medicine, increased biopharmaceutical manufacturing, a growing preference for natural and clean-label excipients, ongoing technological progress in excipient synthesis, and the growth of contract manufacturing organizations (CMOs). Among the key developments expected to shape this period are innovative excipient formulations, improved drug stability solutions, targeted drug delivery approaches, the use of natural and plant-based excipients, and the emergence of multi-functional excipients.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmaceutical Excipients Market Expansion Supported By Key Demand Factors
The expansion of biologics sales is anticipated to drive growth in the pharmaceutical sterility testing market moving forward. Biologics, also referred to as biological products, are medicines sourced from living organisms and encompass a wide array of items, including vaccines, blood and its components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Within biologics, pharmaceutical excipients are utilized to boost stability, optimize formulation, and secure the effective delivery of active biological agents. As an example, in October 2024, the Generics and Biosimilars Initiative, a Belgium-based entity dedicated to delivering reliable scientific insights on generic and biosimilar medications, reported that in 2023, apart from the top nine biologics, two additional complex drugs posted notable sales figures. Specifically, Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both used to treat type 2 diabetes, generated revenues of US$14 billion and US$7.2 billion, respectively. Consequently, the increasing sales of biologics are fueling the pharmaceutical excipients market.
Pharmaceutical Excipients Market Segmentation Trends And Revenue Drivers
The pharmaceutical excipients market covered in this report is segmented –
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts, Oxides, Silicates
2) By Organic Chemicals: Sugars, Polymers, Oils And Fats
3) By Other Products: Natural Excipients, Coatings, Antioxidants
Pharmaceutical Excipients Market Growth Trends Influencing Competitive Dynamics
Key players in the pharmaceutical excipient sector are launching cutting-edge ingredients, specifically high-purity excipients, aimed at improving drug formulation stability, boosting bioavailability, and enabling sophisticated drug delivery mechanisms. High-purity excipients are defined as pharmaceutical components that are refined through rigorous purification methods to eliminate contaminants and impurities. For example, in October 2023, Clariant, a specialty chemical firm headquartered in Switzerland, unveiled three novel VitiPure excipients intended to improve the stability and dissolution of active pharmaceutical ingredients (APIs). The new offerings include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer featuring low bioburden. Designed for a range of drug delivery uses, particularly for delicate formulations such as mRNA vaccines and biological products, these excipients address the increasing need for pure components while complying with strict regulatory standards.
Pharmaceutical Excipients Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma
Access The Complete Pharmaceutical Excipients Market Report:
Pharmaceutical Excipients Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
